{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:07:34Z","timestamp":1771654054266,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012829","name":"The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81904104"],"award-info":[{"award-number":["81904104"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174301"],"award-info":[{"award-number":["82174301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030311009"],"award-info":[{"award-number":["2017A030311009"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2023A03J0744"],"award-info":[{"award-number":["2023A03J0744"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.intimp.2024.111487","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:43:50Z","timestamp":1704415430000},"page":"111487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Periplogenin inhibits pathologic synovial proliferation and infiltration in rheumatoid arthritis by regulating the JAK2\/3-STAT3 pathway"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2673-493X","authenticated-orcid":false,"given":"Xiaoqin","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-6127","authenticated-orcid":false,"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shudi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minzhen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changsong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.intimp.2024.111487_b0005","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/jama.2022.0786","article-title":"What Is Rheumatoid Arthritis?","volume":"327","author":"Smith","year":"2022","journal-title":"JAMA."},{"key":"10.1016\/j.intimp.2024.111487_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107392","article-title":"Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes","volume":"93","author":"Wu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111487_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.816839","article-title":"Inflammasome and Its Therapeutic Targeting in Rheumatoid Arthritis","volume":"12","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.intimp.2024.111487_b0020","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.3390\/ijms222010922","article-title":"Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis","volume":"22","author":"Kondo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10086","key":"10.1016\/j.intimp.2024.111487_b0025","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet."},{"key":"10.1016\/j.intimp.2024.111487_b0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.922111","article-title":"Two Main Cellular Components in Rheumatoid Arthritis: Communication Between T Cells and Fibroblast-Like Synoviocytes in the Joint Synovium","volume":"13","author":"Tu","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2024.111487_b0035","article-title":"Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis","volume":"82","author":"Kugler","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.111487_b0040","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/rheumatology\/kex426","article-title":"Targeted inhibition of Janus kinases abates interfon gamma-induced invasive behaviour of fibroblast-like synoviocytes","volume":"57","author":"Karonitsch","year":"2018","journal-title":"Rheumatology (Oxford)."},{"issue":"9","key":"10.1016\/j.intimp.2024.111487_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102884","article-title":"Role of interleukin-6 in bone destruction and bone repair in rheumatoid arthritis","volume":"20","author":"Takeuchi","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.111487_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120516","article-title":"Underpinning IL-6 biology and emphasizing selective JAK blockade as the potential alternate therapeutic intervention for rheumatoid arthritis","volume":"298","author":"Srivastava","year":"2022","journal-title":"Life Sci."},{"issue":"13","key":"10.1016\/j.intimp.2024.111487_b0055","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and Management of Rheumatoid Arthritis: A Review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA."},{"issue":"1","key":"10.1016\/j.intimp.2024.111487_b0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2024.111487_b0065","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.3390\/ijms22126211","article-title":"Role of JAK\/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms","volume":"22","author":"Montero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.111487_b0070","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2021.08.004","article-title":"JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition","volume":"148","author":"Luo","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"issue":"42","key":"10.1016\/j.intimp.2024.111487_b0075","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","article-title":"The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","volume":"42","author":"Baldini","year":"2021","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.intimp.2024.111487_b0080","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0955-0674(00)00199-X","article-title":"The Stat family in cytokine signaling","volume":"13","author":"Ihle","year":"2001","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.intimp.2024.111487_b0085","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2022.11.011","article-title":"The STAT family: Key transcription factors mediating crosstalk between cancer stem cells and tumor immune microenvironment","volume":"88","author":"Zhu","year":"2023","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.intimp.2024.111487_b0090","doi-asserted-by":"crossref","first-page":"668","DOI":"10.55563\/clinexprheumatol\/e7ayu8","article-title":"JAK\/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis","volume":"39","author":"Crispino","year":"2021","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111487_b0095","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.semarthrit.2020.10.008","article-title":"The Jak\/STAT pathway: A focus on pain in rheumatoid arthritis","volume":"51","author":"Simon","year":"2021","journal-title":"Semin. Arthritis. Rheum."},{"key":"10.1016\/j.intimp.2024.111487_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108793","article-title":"Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis","volume":"230","author":"Liu","year":"2021","journal-title":"Clin. Immunol."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2024.111487_b0105","doi-asserted-by":"crossref","first-page":"ii24","DOI":"10.1093\/rheumatology\/keaa895","article-title":"The safety of JAK-1 inhibitors","volume":"60","author":"Clarke","year":"2021","journal-title":"Rheumatology (Oxford)."},{"issue":"23","key":"10.1016\/j.intimp.2024.111487_b0110","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1038\/s41388-021-01817-2","article-title":"Periplogenin suppresses the growth of esophageal squamous cell carcinoma in vitro and in vivo by targeting STAT3","volume":"40","author":"Hu","year":"2021","journal-title":"Oncogene."},{"key":"10.1016\/j.intimp.2024.111487_b0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bcp.2016.02.001","article-title":"Periplogenin induces necroptotic cell death through oxidative stress in HaCaT cells and ameliorates skin lesions in the TPA- and IMQ-induced psoriasis-like mouse models","volume":"105","author":"Zhang","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111487_b0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/1871520620666200708104559","article-title":"Periplogenin Activates ROS-ER Stress Pathway to Trigger Apoptosis via BIP-eIF2\u03b1- CHOP and IRE1\u03b1-ASK1-JNK Signaling Routes","volume":"21","author":"Yang","year":"2021","journal-title":"Anticancer Agents Med. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2024.111487_b0125","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12016-020-08786-6","article-title":"Prospects in Connective Tissue Diseases","volume":"59","author":"You","year":"2020","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.111487_b0130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard-2022-223050","article-title":"ARTIS study group, Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis","volume":"82","author":"Molander","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.111487_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153801","article-title":"Anti-inflammatory and osteoprotective effects of Chikusetsusaponin \u2163a on rheumatoid arthritis via the JAK\/STAT signaling pathway","volume":"93","author":"Guo","year":"2021","journal-title":"Phytomedicine."},{"key":"10.1016\/j.intimp.2024.111487_b0140","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Front. Biosci."},{"issue":"11","key":"10.1016\/j.intimp.2024.111487_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108158","article-title":"The Natural Compound Notopterol Binds and Targets JAK2\/3 to Ameliorate Inflammation and Arthritis","volume":"32","author":"Wang","year":"2020","journal-title":"Cell Rep."},{"issue":"11","key":"10.1016\/j.intimp.2024.111487_b0150","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40265-017-0775-4","article-title":"Abatacept: A Review in Rheumatoid Arthritis","volume":"77","author":"Blair","year":"2017","journal-title":"Drugs."},{"issue":"1","key":"10.1016\/j.intimp.2024.111487_b0155","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC201901010","article-title":"Rheumatoid Arthritis","volume":"170","author":"Sparks","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.111487_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103056","article-title":"Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease","volume":"21","author":"Akiyama","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2024.111487_b0165","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijpharm.2016.02.024","article-title":"Tumor targeted delivery of octreotide-periplogenin conjugate: Synthesis, in vitro and in vivo evaluation","volume":"502","author":"Zhang","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.intimp.2024.111487_b0170","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.246","article-title":"The interplay between inflammation and metabolism in rheumatoid arthritis","volume":"6","author":"Chimenti","year":"2015","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.intimp.2024.111487_b0175","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1136\/ard-2022-222605","article-title":"Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-\u03b1-mediated ERK1\/2 and JAK-STAT1 pathways","volume":"81","author":"Qin","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2024.111487_b0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.939265","article-title":"Evaluation of the immune feature of ACPA-negative rheumatoid arthritis and the clinical value of matrix metalloproteinase-3","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.111487_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108965","article-title":"Interplay of redox imbalance with matrix gelatinases in neutrophils and their association with disease severity in rheumatoid arthritis patients","volume":"237","author":"Kaushal","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.intimp.2024.111487_b0190","doi-asserted-by":"crossref","first-page":"1046810","DOI":"10.3389\/fimmu.2022.1046810","article-title":"Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"Pt A","key":"10.1016\/j.intimp.2024.111487_b0195","article-title":"Qingre Huazhuo Jiangsuan Decoction promotes autophagy by inhibiting PI3K\/AKT\/mTOR signaling pathway to relieve acute gouty arthritis","volume":"302","author":"Liu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2024.111487_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172558","article-title":"PSTPIP2 attenuates joint damage and suppresses inflammation in adjuvant-induced arthritis","volume":"859","author":"Yao","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111487_b0205","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/JIR.S219586","article-title":"JAK Inhibitors in Rheumatoid Arthritis: An Evidence-Based Review on the Emerging Clinical Data","volume":"13","author":"Harrington","year":"2020","journal-title":"J. Inflamm. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.111487_b0210","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","article-title":"Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach","volume":"18","author":"Tanaka","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2024.111487_b0215","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrrheum.2016.69","article-title":"Hypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis","volume":"12","author":"Fearon","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.111487_b0220","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41392-023-01468-7","article-title":"Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer","volume":"8","author":"Xue","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2024.111487_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103276","article-title":"JAK inhibitors and autoimmune rheumatic diseases","volume":"22","author":"Benucci","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2024.111487_b0230","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/13543784.2023.2199919","article-title":"JAK inhibitors for rheumatoid arthritis","volume":"32","author":"Kubo","year":"2023","journal-title":"Expert. Opin. Investig. Drugs."},{"key":"10.1016\/j.intimp.2024.111487_b0235","article-title":"Axial spondyloarthritis: new advances in diagnosis and management","volume":"372","author":"Ritchlin","year":"2021","journal-title":"BMJ."},{"issue":"11","key":"10.1016\/j.intimp.2024.111487_b0240","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1111\/jdv.18263","article-title":"The efficacy and safety of tofacitinib, peficitinib, solcitinib, baricitinib, abrocitinib and deucravacitinib in plaque psoriasis - A network meta-analysis","volume":"36","author":"Zhang","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"10","key":"10.1016\/j.intimp.2024.111487_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102902","article-title":"JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis","volume":"20","author":"Campanaro","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.intimp.2024.111487_b0250","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/rheumatology\/keac068","article-title":"Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data","volume":"61","author":"Barbulescu","year":"2022","journal-title":"Rheumatology (Oxford)."},{"issue":"5","key":"10.1016\/j.intimp.2024.111487_b0255","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3390\/pharmaceutics14051001","article-title":"A Comprehensive Overview of Globally Approved JAK Inhibitors","volume":"14","author":"Shawky","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.intimp.2024.111487_b0260","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/JIR.S356316","article-title":"Application of Baricitinib in Dermatology","volume":"15","author":"Zhang","year":"2022","journal-title":"J. Inflamm. Res."},{"issue":"11","key":"10.1016\/j.intimp.2024.111487_b0265","first-page":"225","article-title":"The role of the JAK\/STAT signal pathway in rheumatoid arthritis","volume":"10","author":"Malemud","year":"2018","journal-title":"Ther. Adv. Musculoskelet Dis."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924000043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924000043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:12:20Z","timestamp":1761588740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924000043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":53,"alternative-id":["S1567576924000043"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111487","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Periplogenin inhibits pathologic synovial proliferation and infiltration in rheumatoid arthritis by regulating the JAK2\/3-STAT3 pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111487"}}